AAAAAA

   
Results: 1-11 |
Results: 11
Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy
Authors: Grenzebach, J Schrappe, M Ludwig, VD Parwaresch, R Zimmermann, M Gadner, H Riehm, H Reiter, A
Citation: J. Grenzebach et al., Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy, ANN HEMATOL, 80, 2001, pp. B73-B76
Clinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter
Authors: Lauten, M Stanulla, M Zimmermann, M Welte, K Riehm, H Schrappe, M
Citation: M. Lauten et al., Clinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter, KLIN PADIAT, 213(4), 2001, pp. 169-174
Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90
Authors: Seidemann, K Tiemann, M Schrappe, M Yakisan, E Simonitsch, I Janka-Schaub, G Dorffel, W Zimmermann, M Mann, G Gadner, H Parwaresch, R Riehm, H Reiter, A
Citation: K. Seidemann et al., Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90, BLOOD, 97(12), 2001, pp. 3699-3706
Long-term results of four consecutive trials in childhood ALL performed bythe ALL-BFM study group from 1981 to 1995
Authors: Schrappe, M Reiter, A Zimmermann, M Harbott, J Ludwig, WD Henze, G Gadner, H Odenwald, E Riehm, H
Citation: M. Schrappe et al., Long-term results of four consecutive trials in childhood ALL performed bythe ALL-BFM study group from 1981 to 1995, LEUKEMIA, 14(12), 2000, pp. 2205-2222
Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: Clinical features, treatment, and results in trials NHL-BFM 86 and 90
Authors: Neth, O Seidemann, K Jansen, P Mann, G Tiemann, M Ludwig, WD Riehm, H Reiter, A
Citation: O. Neth et al., Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: Clinical features, treatment, and results in trials NHL-BFM 86 and 90, MED PED ONC, 35(1), 2000, pp. 20-27
Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy
Authors: Loning, L Zimmermann, M Reiter, A Kaatsch, P Henze, G Riehm, H Schrappe, M
Citation: L. Loning et al., Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy, BLOOD, 95(9), 2000, pp. 2770-2775
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Groupreport
Authors: Reiter, A Schrappe, M Ludwig, WD Tiemann, M Parwaresch, R Zimmermann, M Schirg, E Henze, G Schellong, G Gadner, H Riehm, H
Citation: A. Reiter et al., Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Groupreport, BLOOD, 95(2), 2000, pp. 416-421
Improved outcome in childhood acute lymphoblastic leukemia despite reduceduse of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90
Authors: Schrappe, M Reiter, A Ludwig, WD Harbott, J Zimmermann, M Hiddemann, W Niemeyer, C Henze, G Feldges, A Zintl, F Kornhuber, B Ritter, J Welte, K Gadner, H Riehm, H
Citation: M. Schrappe et al., Improved outcome in childhood acute lymphoblastic leukemia despite reduceduse of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90, BLOOD, 95(11), 2000, pp. 3310-3322
Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia
Authors: Dordelmann, M Reiter, A Borkhardt, A Ludwig, WD Gotz, N Viehmann, S Gadner, H Riehm, H Schrappe, M
Citation: M. Dordelmann et al., Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia, BLOOD, 94(4), 1999, pp. 1209-1217
Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: Results of Dutch Childhood Leukemia Study Group protocol ALL-7 (1988-1991)
Authors: Kamps, WA Bokkerink, JPM Hahlen, K Hermans, J Riehm, H Gadner, H Schrappe, M Slater, R van den Berg-de Ruiter, E Smets, LA de Vaan, GAM Weening, RS van Weerden, JF van Wering, ER van der Does-van den Berg, A
Citation: Wa. Kamps et al., Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: Results of Dutch Childhood Leukemia Study Group protocol ALL-7 (1988-1991), BLOOD, 94(4), 1999, pp. 1226-1236
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster group trial NHL-BFM 90
Authors: Reiter, A Schrappe, M Tiemann, M Ludwig, WD Yakisan, E Zimmermann, M Mann, G Chott, A Ebell, W Klingebiel, T Graf, N Kremens, B Muller-Weihrich, S Pluss, HJ Zintl, F Henze, G Riehm, H
Citation: A. Reiter et al., Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster group trial NHL-BFM 90, BLOOD, 94(10), 1999, pp. 3294-3306
Risultati: 1-11 |